AlphaMol (阿尔法分子科技)

Shen Zhen Shi, China

Drug Discovery Drug Development Biotech Alzheimer(s) Disease

AlphaMol is an AI-based bio-pharmaceutical company focusing on G protein-coupled receptor drug discovery. We aim at discovering and developing new drug molecules to treat major human disorders and diseases including those against infections, cancers, Alzheimer's disease, diabetes, aging and others. We primarily focus on G protein-coupled receptors (GPCRs) related signalling pathway.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out AlphaMol (阿尔法分子科技) on @MedStartr Today #InfectiousDiseases #AlzheimerSDiseaseDementia #Diabetes #DrugDiscovery #DrugDevelopment #Biotech #AlzheimerSDisease #MedMo #MedStartrVentures

https://www.medstartr.ai/s/50rGWnAZwDk

Get Involved in AlphaMol (阿尔法分子科技)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2020
Website: alphamol.com

Disease Areas

Infectious Diseases Alzheimer's & Dementia Diabetes

Technologies

Drug DiscoveryDrug DesignMolecular ModelingG Protein-Coupled Receptor (GPCR) Targeting

🌐Website

What do you think of AlphaMol (阿尔法分子科技)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.